Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1375-1383

  Ortega, Francisco J ^a,b   Mercader, Josep M ^c   Moreno Navarrete, José María ^a,b   Rovira, Oscar ^a,b   Guerra, Ester ^a   Esteve, Eduardo ^a   Xifra, Gemma ^a   Martínez, Cristina ^a   Ricart, Wifredo ^a,b   Rieusset, Jennifer ^d   Rome, Sophie ^d   Karczewska Kupczewska, Monika ^e,f   Straczkowski, Marek ^e,f   Fernández Real, José Manuel ^a,b  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c BARCELONA SUPERCOMPUTING CENTER   (Spain)

^d INSERM   (France)

^e MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^f INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HEPARIN; INSULIN; METFORMIN; MICRORNA; MICRORNA 125B; MICRORNA 126; MICRORNA 130B; MICRORNA 140 5P; MICRORNA 142 3P; MICRORNA 192; MICRORNA 195; MICRORNA 222; MICRORNA 423 5P; MICRORNA 532 5P; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RNA ANALYSIS;

EID: 84899081933     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1847     Document Type: Article

References (38)

1. Poste G. Bring on the biomarkers. Nature 2011;469:156-157
2. Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Diabetologia 2012;55:273-278
3. Rome S. Are extracellular microRNAs involved in type 2 diabetes and related pathologies? Clin Biochem 2013;46:937-945
4. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-233
5. Herrera BM, Lockstone HE, Taylor JM, et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 2010;53:1099-1109
6. Lynn FC. Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends Endocrinol Metab 2009;20:452-459
7. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010;101:2087-2092
8. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012;93:555-562
9. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423-433
10. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011;39:7223-7233
11. Zhu H, Fan GC. Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis 2011;1:138-149
12. Mayr M, Zampetaki A, Willeit P, Willeit J, Kiechl S. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler Thromb Vasc Biol 2013;33:206-214
13. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817
14. Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 2013;9:513-521
15. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res 2011;157:253-264
16. Karczewska-Kupczewska M, Kowalska I, Nikołajuk A, et al. Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fat meal in young healthy male subjects. Diabetes Care 2012;35:358-362
17. Moreno-Navarrete JM, Martínez-Barricarte R, Catalán V, et al. Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes 2010;59:200-209
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223 (Pubitemid 9249478)
19. Karczewska-Kupczewska M, Lelental N, Adamska A, et al. The influence of insulin infusion on the metabolism of amyloid β peptides in plasma. Alzheimers Dement 2013;9:400-405
20. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034
21. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13-20 (Pubitemid 16011804)
22. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007;117:2369-2376 (Pubitemid 47494334)
23. Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 2012;97:E2271-E2276
24. Kong L, Zhu J, Han W, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 2011;48:61-69
25. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss ofMicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010;21:438-447
26. Klein D, Misawa R, Bravo-Egana V, et al. MicroRNA expression in alpha and beta cells of human pancreatic islets. PLoS ONE 2013;8:e55064
27. Ortega FJ, Mercader JM, Catalán V, et al. Targeting the circulating microRNA signature of obesity. Clin Chem 2013;59:781-792
28. Ortega FJ, Moreno-Navarrete JM, Pardo G, et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS ONE 2010;5:e9022
29. Hofsø D, Jenssen T, Hager H, Røislien J, Hjelmesaeth J. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg 2010;20:302-307
30. Joyce CE, Zhou X, Xia J, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet 2011;20:4025-4040
31. Makino K, Jinnin M, Kajihara I, et al. Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol 2012;37:34-39
32. Kim D, Song J, Kim S, Kang SS, Jin EJ. MicroRNA-142-3p regulates TGF-β3-mediated region-dependent chondrogenesis by regulating ADAM9. Biochem Biophys Res Commun 2011;414:653-659
33. Nicolas FE, Pais H, Schwach F, et al. Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 2008;14:2513-2520
34. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-2446 (Pubitemid 24177157)
35. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476-487
36. Coleman CB, Lightell DJ Jr, Moss SC, Bates M, Parrino PE, Woods TC. Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin. Mol Cell Endocrinol 2013;374:125-129
37. Baggish AL, Hale A, Weiner RB, et al. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 2011;589:3983-3994
38. Bye A, Røsjø H, Aspenes ST, Condorelli G, Omland T, Wisløff U. Circulating microRNAs and aerobic fitness - the HUNT-Study. PLoS ONE 2013;8:e57496